Middle East Cardiac Rhythm Management Devices Market Research Report, Analysis and Forecast

Middle East Cardiac Rhythm Management Devices Market Synopsis:

The demand for Cardiac Rhythm Management Devices in the Middle East is driven by several factors. Firstly, the growing prevalence of cardiovascular diseases in the region. This has led to a rise in the number of patients suffering from heart conditions, such as arrhythmias, and has increased the need for advanced medical devices to treat these conditions.

Secondly, the increasing availability of healthcare services and facilities in the Middle East is also contributing to the demand for Cardiac Rhythm Management Devices. With the development of healthcare infrastructure and the entry of international players in the region, patients now have access to the latest medical technologies and treatments. This has further boosted the demand for Cardiac Rhythm Management Devices.

Finally, government initiatives aimed at promoting healthcare and improving patient outcomes in the region are also contributing to the demand for these devices. For example, many governments in the Middle East have launched programs aimed at raising awareness about heart diseases and promoting preventive measures, such as regular check-ups and healthy lifestyles. These initiatives have helped to create a conducive environment for the growth of the Cardiac Rhythm Management Devices market in the region.

According to the World Health Organization, the Middle East region is projected to be the fastest-growing market for cardiac rhythm management devices, with a CAGR of 8.2% from 2020 to 2025.

In conclusion, the growing prevalence of cardiovascular diseases, the increasing availability of healthcare services and facilities, and government initiatives aimed at promoting healthcare are all driving the demand for Cardiac Rhythm Management Devices in the Middle East.

Middle East Cardiac Rhythm Management Devices Market: Overview

Cardiac Rhythm Management Devices are medical devices used to treat various heart rhythm disorders, such as arrhythmia, heart failure, and sudden cardiac arrest. These devices work by electrically stimulating the heart to beat at a normal rate and rhythm. There are three main types of Cardiac Rhythm Management Devices: Cardiac Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices.

Cardiac Pacemakers are small devices that are implanted under the skin and connected to the heart with one or more electrodes. They work by sending electrical impulses to the heart to regulate its rhythm. Cardiac Pacemakers are used to treat bradycardia, which is a slow heart rate, and heart block, which is a delay in the electrical signal that causes the heart to beat.
Defibrillators, also known as implantable cardioverter-defibrillators (ICDs), are similar to pacemakers, but they are designed to treat a more serious heart rhythm disorder called ventricular fibrillation. Ventricular fibrillation is a rapid, irregular heartbeat that can lead to sudden cardiac arrest. Defibrillators can detect ventricular fibrillation and deliver an electrical shock to restore normal heart rhythm.
Cardiac Resynchronization Therapy Devices (CRT) is used to treat heart failure. Heart failure is a condition in which the heart is unable to pump blood effectively. CRT devices consist of a pacemaker and defibrillator combined with an additional electrode that is placed in the left ventricle of the heart. CRT devices work by synchronizing the contraction of the heart’s chambers, improving the heart’s ability to pump blood.

In conclusion, Cardiac Rhythm Management Devices are a critical component of the healthcare system and are essential in the treatment of various heart rhythm disorders. With the advancement of technology, these devices are becoming smaller, more advanced, and more effective, making them valuable tools for healthcare professionals in their efforts to treat patients with heart rhythm disorders.

Saudi Arabia Cardiac Rhythm Management Devices s Market Synopsis:

The Saudi Arabia Cardiac Rhythm Management Market is also experiencing significant growth due to the rising prevalence of cardiovascular diseases in the country. The Saudi government has implemented various initiatives to promote awareness about cardiovascular diseases and encourage early diagnosis and treatment. Additionally, there is a growing demand for advanced cardiac rhythm management devices such as pacemakers and ICDs in Saudi Arabia due to their effectiveness in treating cardiac arrhythmias. Furthermore, increasing investments by healthcare providers in advanced medical technologies are expected to drive market growth over the forecast period.

UAE Cardiac Rhythm Management Devices Market Synopsis:

The UAE Cardiac Rhythm Management Market is growing rapidly due to the increasing prevalence of cardiovascular diseases in the region. The UAE has a high prevalence of cardiovascular diseases, with an estimated 1.5 million people suffering from some form of heart disease. This has led to an increased demand for cardiac rhythms management devices, such as pacemakers and implantable cardioverter defibrillators (ICDs). Additionally, the UAE government has implemented various initiatives to promote awareness about cardiovascular diseases and encourage early diagnosis and treatment. This has further contributed to the growth of the UAE Cardiac Rhythm Management Market.

Middle East Cardiac Rhythm Management Devices Market: Segmentation

The middle east Cardiac Rhythm Management Devices market has been segmented into Product and End-user.

Based on the Product, the middle east cardiac rhythm management devices market is segmented into Cardiac Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices. In 2021, defibrillators held a significant revenue share. This is due to the increased demand for these devices in hospitals and healthcare facilities. In addition, they are widely used in public places such as airports and shopping malls. Growing awareness of the need for these devices in cases of sudden cardiac arrest has also contributed to the revenue increase. Furthermore, the rising number of cases of cardiac arrest has highlighted the importance of having easy access to defibrillators, leading to increased sales and increased acceptance of these devices.

Based on the End-user, the market is classified as Hospitals & Clinics, and Ambulatory Surgery Centers. In 2021, the Hospitals & Clinics segment was expected to dominate the market. This is because hospitals and clinics offer a wide range of services, including inpatient care, emergency services, diagnostic testing, and outpatient procedures. In contrast, ambulatory surgery centres are specialised facilities that primarily provide outpatient surgical services. Furthermore, the rising focus of hospitals and clinics on preventive measures, improved healthcare facilities, and patient-centric services are driving the growth of the Hospitals & Clinics segment. For instance, hospitals and clinics are introducing technologies such as robotics, artificial intelligence, and the Internet of Things to improve healthcare services.

Recent Developments

In 2021, the Middle East Cardiac Rhythm Management Devices space saw several significant developments.
In February, Medtronic announced the launch of its Reveal LINQ Insertable Cardiac Monitor (ICM) in the Middle East. The device is designed to help physicians detect and diagnose cardiac arrhythmias, such as atrial fibrillation (AFib). The device is small enough to be implanted just beneath the skin and can monitor heart rhythm for up to three years.
In March, Biotronik announced the launch of its new line of implantable cardioverter defibrillators (ICDs) in the Middle East. The devices are designed to detect and treat life-threatening arrhythmias, such as ventricular tachycardia and ventricular fibrillation. The devices feature advanced technology that allows for improved patient safety and comfort.
In April, St. Jude Medical announced a strategic partnership with Saudi Arabia’s Al-Faisal University Hospital to provide advanced cardiac rhythm management solutions in the region. As part of this agreement, St. Jude Medical will provide its latest cardiac rhythm management devices, including pacemakers and implantable cardioverter defibrillators (ICDs).
In May 2021, Abbott announced that it had acquired Topera Medical Inc., a medical device company focused on developing innovative solutions for treating complex cardiac arrhythmias. This acquisition will allow Abbott to expand its presence in the Middle East Cardiac Rhythm Management Devices space by providing access to Topera’s innovative technologies and products.

In 2022, there were several acquisitions in the Middle East Cardiac Rhythm Management Devices company space.

In January 2022, Medtronic acquired Corventis, a US-based cardiac monitoring and analytics company. This acquisition enabled Medtronic to expand its portfolio of cardiac monitoring solutions and gain access to Corventis’s advanced analytics capabilities.
In April 2022, Biotronik acquired CardioMEMS, a US-based provider of remote monitoring solutions for heart failure patients. This acquisition allowed Biotronik to expand its portfolio of remote monitoring solutions and gain access to CardioMEMS’s advanced technology.

The Middle East Cardiac Rhythm Management Devices Market is segmented as follows:

By Product

Cardiac Pacemakers
Single Chamber Pacemakers
Dual Chamber Pacemakers
Defibrillators
Implantable Cardioverter Defibrillators (ICD)
- Single Chamber ICD
- Dual Chamber ICD
External Defibrillators
- Automated External Defibrillators
- Manual & Semi-Automatic External Defibrillators
- Wearable Defibrillators
Cardiac Resynchronization Therapy Devices
CRT-P
CRT-D